Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1160 of 6351
-
Real-world data on semaglutide weight loss in 35,000 adults
Disease control CompletedThe purpose of the study is to assess the weight loss in participants treated with commercially available semaglutide according to routine clinical practice at the discretion of the treating physician.
Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Could a mother's stress leave a mark on her baby's genes? a large study investigates.
Knowledge-focused Recruiting nowThe University of Iowa's Center for Disabilities and Development is researching how pregnancy, early childhood experiences, and genetic factors influence child development, with a focus on autism spectrum disorder (ASD). Pregnant women are invited to participate in a study that t…
Sponsor: University of Iowa • Aim: Knowledge-focused
Last updated Aug 05, 2026 00:00 UTC
-
New radiation technique aims to zap prostate tumors with fewer side effects
Disease control Recruiting nowThis clinical trial tests the effect of focal radiation therapy, high dose rate-brachytherapy (HDR-BT), in treating patients with prostate cancer. Prostate cancer is the most diagnosed cancer in men and there are many treatments available, including surgery and radiation therapy.…
Sponsor: Jonsson Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
New weight loss drugs enter human testing – could they beat placebo?
Disease control Recruiting nowThis study is being done to learn about the safety and effects of the study drugs, PF-08653945 and PF-08653944, when given alone or together for weight loss, compared to a placebo (a dummy drug that has no active ingredient in it).
Phase 2 • Sponsor: Pfizer • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
Gene therapy gel targets rare blistering skin disease
Disease control Recruiting nowAn open-label study to evaluate the safety and efficacy of KB111 in pediatric and adult subjects with Hailey-Hailey Disease
Early phase 1 • Sponsor: Krystal Biotech, Inc. • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
New support team aims to bridge the gap from hospital to mental health care for psychosis
Disease control Recruiting nowThis study is testing a new approach to help people with first episode psychosis transition successfully from the hospital to outpatient mental health care. Many patients lose contact with services after they leave the hospital, which can lead to worse outcomes. The investigators…
Sponsor: University of Chicago • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Could an Alzheimer's drug slow Parkinson's? new trial aims to find out
Disease control Not yet recruitingThis study aimed to determine the efficacy of amyloid clearance of lecanemab in patients with Parkinson's disease (PD) with amyloid co-pathology. Lecanemab, an anti-amyloid monoclonal antibody, was apporoved by the US FDA in July 2023 and in South Korea in May 2024, as a disease-…
Sponsor: Yonsei University • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New triple therapy aims to protect kidneys in diabetes patients
Disease control Not yet recruitingThe purpose of this study is to evaluate whether adding dulaglutide to the combination therapy of Sodium-Glucose Co-Transporter 2 Inhibitors(SGLT2i) and finerenone can provide additional kidney protection and safety for Chinese adults with Type 2 Diabetes Mellitus(T2DM) and Chron…
Phase 4 • Sponsor: First Affiliated Hospital of Wannan Medical College • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Could a biologic drug free severe asthma patients from High-Dose steroids?
Disease control By invitation onlyTo evaluate the relationship between starting tezepelumab treatment followed by tapering of inhaled corticosteroid (ICS) and ICS dose, metabolic outcomes, asthma control and exacerbation rate in a real world setting
Sponsor: Franciscus Gasthuis • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
Could a brain lipid injection ease Parkinson's motor swings?
Disease control Not yet recruitingThis is a multicenter, randomized, double-blind, placebo-controlled, parallel-group, phase 2 study. A total of 276 eligible Parkinson's disease participants with motor fluctuations will be enrolled and assigned to one of three cohorts. Within each cohort, participants will be ran…
Phase 2 • Sponsor: Qilu Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
AI-Powered ECG may spot hidden heart disease in just one minute
Diagnosis Not yet recruitingIt is a prospective, controlled, single-center, non-randomized, observational study. Two patient groups are planned for inclusion: the first - 200 patients with significant coronary artery stenosis confirmed by coronary angiography (CAG) or multislice computed tomography (MSCT) r…
Sponsor: I.M. Sechenov First Moscow State Medical University • Aim: Diagnosis
Last updated Jun 27, 2026 12:31 UTC
-
Fibroid removal before IVF: a Game-Changer for fertility?
Disease control Not yet recruitingUterine fibroids are the most common benign tumors of the female reproductive system and are frequently encountered in women of reproductive age. Although many fibroids are asymptomatic, 5%-10% of women with infertility have coexisting fibroids, and in a small proportion fibroids…
Sponsor: Peking Union Medical College Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
AI could slash unnecessary prostate biopsies in 'Gray Zone' patients
Diagnosis OngoingThis project aims to develop a precision screening and diagnostic solution for prostate cancer based on multimodal artificial intelligence, focusing on addressing the diagnostic challenge in patients within the PSA "gray zone" of 4-10 ng/mL. The project will integrate multidimens…
Sponsor: Guangxi Medical University • Aim: Diagnosis
Last updated Jun 27, 2026 14:00 UTC
-
New study aims to improve breast cancer treatment before surgery
Knowledge-focused Not yet recruitingThis study is an observational study that retrospectively collects data of triple-negative breast cancer patients who received neoadjuvant therapy. It compares the bpCR rate, apCR rate, and tpCR rate of patients treated with chemotherapy or immunotherapy, in order to analyze the …
Sponsor: The First Affiliated Hospital with Nanjing Medical University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:06 UTC
-
Blood test may spot hidden breast cancer months before scans
Diagnosis Not yet recruitingTriple-negative breast cancer (TNBC) is an aggressive type of breast cancer, often with poor outcomes. Currently, follow-up for TNBC consists of physical exams and annual breast imaging, with additional scans only if symptoms appear. This approach may delay the detection of the c…
Sponsor: Sunnybrook Health Sciences Centre • Aim: Diagnosis
Last updated Jun 27, 2026 11:02 UTC
-
Can a THC-Based drug calm Alzheimer's agitation? new trial aims to find out
Symptom relief Not yet recruitingThis study tests a medication called dronabinol in people with Alzheimer's disease. First, participants go through up to 4 weeks of screening. Then, over 2 weeks, the dose of the study drug is slowly increased. For the next 10 weeks, participants stay on either dronabinol or a pl…
Phase 2/3 • Sponsor: Benuvia Therapeutics Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 09:07 UTC
-
AI could help pick surgery or ablation for liver cancer patients
Knowledge-focused Not yet recruitingThis study aims to address the issue of a lack of individualized basis for selecting liver resection (LH) or microwave ablation (MWA) in early-stage hepatocellular carcinoma (HCC) patients to reduce the early recurrence rate (≤2 years). Given that existing machine learning-based …
Sponsor: The First Hospital of Jilin University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:32 UTC
-
New drug RC288 targets Hard-to-Treat tumors in early trial
Disease control Not yet recruitingThe primary objective is to evaluate the safety and tolerability of RC288; determine the maximum tolerated dose (MTD) and/or maximum administered dose (MAD) of RC288; and determine the recommended phase 2 dose (RP2D), and assess the efficacy of RC288 at the RP2D dose;
Phase 1/2 • Sponsor: RemeGen Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
When to treat? new trial aims to optimize therapy for oligometastatic esophageal and gastric cancer
Disease control Recruiting nowPurpose of the Study: This clinical study investigates whether a shorter or longer duration of systemic therapy before local treatment (surgery or radiation) results in better disease control in patients with esophageal or gastric cancer with a limited number of metastases, also…
Phase 2 • Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
New hope for kids with leukemia: drug trial targets cancer control
Disease control Recruiting nowThe aim of this study is to support development of asciminib in the pediatric population (1 to \< 18 years) with Ph+ CML-CP. The study will evaluate the efficacy and safety of asciminib in pediatric formulation (weigh-based dose, fed state) or adult formulation (fasted) in newly …
Phase 2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC